Recombinant CCL2 (Carlumab Biosimilar) antibody
The Human Monoclonal anti-CCL2 (Carlumab Biosimilar) antibody (ABIN7538059) specifically detects CCL2 (Carlumab Biosimilar) in ELISA and WB.
The antibody is reactive with Human samples.
Catalog No. ABIN7538059
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant CCL2 (Carlumab Biosimilar) antibody (ABIN7538059)
Target
CCL2 (Carlumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This CCL2 (Carlumab Biosimilar) antibody is un-conjugated
Application
ELISA, Western Blotting (WB)
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Carlumab Biosimilar – Anti-CCL2 mAb - Research Grade
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Purity
- > 85%
-
Isotype
- IgG1 kappa
-
-
anti-CCL2 (Carlumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Human Monoclonal unconjugated Recombinant Antibody
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer PH7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- CCL2 (Carlumab Biosimilar)
-
Background
- Carlumab is a human anti-CCL2 (chemokine ligand 2) antibody with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer.
-
CAS-No
- 915404-94-3
Target
-
You are here:
